Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.

Completed

Conditions studied: Myocardial Ischemia

In brief

A magnetocardiograph (MCG) is a device capable of recording of magnetic fields arising from the electrical activity of the heart with traces similar to an electrocardiogram (ECG). This system was developed as a noninvasive, non-contact diagnostics of obstructive coronary artery disease (CAD), and especially of lack of oxygen in the heart as in a heart attack. The overall objective of this study is to demonstrate the efficacy of this MCG device for the detection and diagnosis of lack of oxygen of the heart in patients with chest pain.

Key facts

Study ID

NCT00169975

Run by

Mayo Clinic

People needed

137

Starts

2004-08-01

Expected to finish

2008-02-01

Last updated by the study team

2011-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients classified as having High Risk Unstable Angina according to the ACCIAHA guidelines.
• Age ≥ 18 years.

You may not qualify if…

• Hemodynamically unstable patients.
• Patients who just prior to or just after admission exhibit tachycardia with heart rates exceeding 150 bpm.
• Patients with third degree AV Block.
• Patients with pacemakers or internal cardiac defibrillators.
• Patients who cannot lie in a supine position for the MCG examination.
• Patients who refuse entry into the registry

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.